Prosaposin gene expression in normal and dystrophic RCS rat retina

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 5, 2004, Pages 1297-1305

  Van Den Berghe, Loïc ^a   Sainton, Karine ^a   Gogat, Karïn ^a   Marchant, Dominique ^a   Dufour, Eric ^a   Bonnel, Sébastien ^a   Gadin, Stéphanie ^a   Menasche, Maurice ^a   Abitbol, Marc ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; MESSENGER RNA; PROSAPOSIN; RNA; GLYCOPROTEIN; PSAP PROTEIN, RAT; SPHINGOLIPID ACTIVATOR PROTEIN;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; EYE DEVELOPMENT; GENE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MONOLAYER CULTURE; NERVE CELL; NEWBORN; NONHUMAN; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; RAT STRAIN; RDY GENE; RETINA DYSTROPHY; RETINA ROD OUTER SEGMENT; RNA ANALYSIS; ROYAL COLLEGE OF SURGEONS RAT; SIGNAL SEQUENCE TRAP SYSTEM; TECHNIQUE; AMINO ACID SEQUENCE; ANIMAL; GENE LIBRARY; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; RETINA; RETINA DEGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; GENE EXPRESSION; GENE LIBRARY; GLYCOPROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOLECULAR SEQUENCE DATA; RATS; RATS, MUTANT STRAINS; RETINA; RETINAL DEGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SAPOSINS; SWINE;

EID: 2442670633     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-1048     Document Type: Article

References (73)

1. Sheedlo HJ, Li L, Fan W, Turner JE. Retinal pigment epithelial cell support of photoreceptor survival in vitro. In Vitro Cell Dev Biol Anim. 1995;31:330-333.
2. Sheedlo HJ, Turner JE. Effects of retinal pigment epithelial cell-secreted factors on neonatal rat retinal explant progenitor cells. J Neurosci Res. 1996;44:519-531.
3. Sheedlo HJ, Turner JE. Influence of a retinal pigment epithelial cell factor(s) on rat retinal progenitor cells. Brain Res Dev Brain Res. 1996;93:88-99.
4. Sheedlo HJ, Nelson TH, Lin N, Rogers TA, Roque RS, Turner JE. RPE secreted proteins and antibody influence photoreceptor cell survival and maturation. Brain Res Dev Brain Res 1998;107:57-69.
5. Lin N, Fan W, Sheedlo HJ, Aschenbrenner JE, Turner JE. Photoreceptor repair in response to RPE transplants in RCS rats: outer segment regeneration. Curr Eye Res. 1996;15:1069-1077.
6. Campochiaro PA. Cytokine production by retinal pigmented epithelial cells. Int Rev Cytol. 1993;146:75-82.
7. Campochiaro PA, Hackett SF, Vinores SA. Growth factors in the retina and retinal pigmented epithelium. Prog Retin Eye Res. 1996;15:547-567.
8. Holtkamp GM, Kijlstra A, Peek R, de Vos AF. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res. 2001;20:29-48.
9. Steinberg RH. Survival factors in retinal degenerations. Curr Opin Neurobiol. 1994;4:515-524.
10. Daiger SP, Sullivan LS, Bowne SJ. Cloned and/or mapped genes causing retinal diseases. Ret Net is available at http://www.sph.uth.tmc.edu/RetNet/ provided in the public domain by the University of Texas Houston Health Science Center, Houston, TX.
11. Saleem RA, Walter MA. The complexities of ocular genetics. Clin Genet. 2002;61:79-88.
12. Phelan JK, Bok D. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis. 2000;6:116-124.
13. Clarke G, Heon E, McInnes RR. Recent advances in the molecular basis of inherited photoreceptor degeneration. Clin Genet. 2000;57:313-329.
14. Klein RD, Gu Q, Goddard A, Rosenthal A. Selection for genes encoding secreted proteins and receptors. Proc Natl Acad Sci USA. 1996;93:7108-7313.
15. Jacobs KA, Collins-Racie LA, Colbert M, et al. A genetic selection for isolating cDNAs encoding secreted proteins. Gene 1997;198:289-296.
16. Kishimoto Y, Hiraiwa M, O'Brien JS. Saposins: structure, function, distribution, and molecular genetics. J Lipid Res. 1992;33:1255-1267.
17. Sandhoff K, Kolter T, Harzer K. Sphingolipid activator proteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:3371-3388.
18. Hiraiwa M, Martin BM, Kishimoto Y, Conner GE, Tsuji S, O'Brien JS. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. Arch Biochem Biophys. 1997;341:17-24.
19. Sandhoff K, Klein A. Intracellular trafficking of glycosphingolipids: role of sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion. FEBS Lett. 1994;346:103-107.
20. Sandhoff K, Kolter T. Processing of sphingolipid activator proteins and the topology of lysosomal digestion. Acta Biochim Pol. 1998;45:373-384.
21. Sandhoff K, Kolter T. Biosynthesis and degradation of mammalian glycosphingolipids. Philos Trans R Soc Lond B Biol Sci. 2003;358:847-861.
22. Bierfreund U, Kolter T, Sandhoff K. Sphingolipid hydrolases and activator proteins. Methods Enzymol. 2000;311:255-276.
23. Kolter T, Sandhoff K. Recent advances in the biochemistry of sphingolipidoses. Brain Pathol. 1998;8:79-100.
24. Kondoh K, Hineno T, Sano A, Kakimoto Y. Isolation and characterization of prosaposin from human milk. Biochem Biophys Res Commun. 1991;181:286-292.
25. Kondoh K, Sano A, Kakimoto Y, Matsuda S, Sakanaka M. Distribution of prosaposin-like immunoreactivity in rat brain. J Comp Neurol. 1993;334:590-602.
26. Hiraiwa M, O'Brien JS, Kishimoto Y, et al. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). Arch Biochem Biophys. 1993;304:110-116.
27. Hineno T, Sano A, Kondoh K, Ueno S, Kakimoto Y, Yoshida K. Secretion of sphingolipid hydrolase activator precursor, prosaposin. Biochem Biophys Res Commun. 1991;176:668-674.
28. Patton S, Carson GS, Hiraiwa M, O'Brien JS, Sano A. Prosaposin, a neurotrophic factor: presence and properties in milk. J Dairy Sci. 1997;80:264-272.
29. O'Brien JS, Kretz KA, Dewji N, Wenger DA, Esch F, Fluharty AL. Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus. Science. 1998;241:1098-1101.
30. Sano A, Hineno T, Mizuno T, et al. Sphingolipid hydrolase activator proteins and their precursors. Biochem Biophys Res Commun. 1989;165:1191-1197.
31. O'Brien JS, Carson GS, Seo HC, Hiraiwa M, Kishimoto Y. Identification of prosaposin as a neurotrophic factor, Proc Natl Acad Sci USA. 1994;91:9593-9596.
32. Kotani Y, Matsuda S, Wen TC, et al. A hydrophilic peptide comprising 18 amino acid residues of the prosaposin sequence has neurotrophic activity in vitro and in vivo: prosaposin facilitates sciatic nerve regeneration in vivo. J Neurochem. 1996;66:2197-2200.
33. Hiraiwa M, Taylor EM, Campana WM, Darin SJ, O'Brien JS. Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc Natl Acad Sci USA. 1997;94:4778-4781.
34. Calcutt NA, Campana WM, Eskeland NL, et al. Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats. J Neuropathol Exp Neurol. 1999;58:628-636.
35. Igase K, Tanaka J, Kumon Y, et al. An 18-mer peptide fragment of prosaposin ameliorates place navigation disability, cortical infarction, and retrograde thalamic degeneration in rats with focal cerebral ischemia. J Cereb Blood Flow Metab, 1999;19:298-306.
36. Hozumi I, Hiraiwa M, Inuzuka T, et al. Administration of prosaposin ameliorates spatial learning disturbance and reduces cavity formation following stab wounds in rat brain. Neurosci Lett. 1999;267:73-76.
37. Hiraiwa M, Campana WM, Mizisin AP, Mohiuddin L, O'Brien JS. Prosaposin: a myelinotrophic protein that promotes expression of myelin constituents and is secreted after nerve injury. Glia. 1999;26:353-360.
38. Tsuboi K, Hiraiwa M, O'Brien, JS. Prosaposin prevents programmed cell death of rat cerebellar granule neurons in culture. Brain Res Dev Brain Res. 1998;110:249-255.
39. Misasi R, Sorice M, Di Marzio L, et al. Prosaposin treatment induces PC12 entry in the S phase of the cell cycle and prevents apoptosis: activation of ERKs and sphingosine kinase. FASEB J. 2001;15:467-474.
40. Sano A, Matsuda S, Wen TC, et al. Protection by prosaposin against ischemia-induced learning disability and neuronal loss. Biochem Biophys Res Commun. 1994;204:994-1000.
41. Yokota N, Uchijima M, Nishizawa S, Namba H, Koide Y. Identification of differentially expressed genes in rat hippocampus after transient global cerebral ischemia using subtractive cDNA cloning based on polymerase chain reaction. Stroke. 2001;32:168-174.
42. Morales CR, Zhao Q, Lefrancois S, Ham D. Role of prosaposin in the male reproductive system: effect of prosaposin inactivation on the testis, epididymis, prostate, and seminal vesicles. Arch Androl. 2000;44:173-186.
43. Igdoura SA, Morales CR. Role of sulfated glycoprotein-1 (SGP-1) in the disposal of residual bodies by Sertoli cells of the rat. Mol Reprod Dev. 1995;40:91-102.
44. Schnabel D, Schroder M, Sandhoff K. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett. 1991;284:57-59.
45. Rafi MA, de Gala G, Zhang XL, Wenger DA. Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency. Somat Cell Mol Genet. 1993;19:1-7.
46. Kretz KA, Carson GS, Morimoto S, Kishimoto Y, Fluharty AL, O'Brien JS. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect. Proc Natl Acad Sci USA. 1990;87:2541-2544.
47. Rafi MA, Zhang XL, DeGala G, Wenger DA. Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy. Biochem Biophys Res Commun. 1990;166:1017-1023.
48. Holtschmidt H, Sandhoff K, Kwon HY, Harzer K, Nakano T, Suzuki K. Sulfatide activator protein: alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease. J Biol Chem. 1991;266:7556-7560.
49. Zhang XL, Rafi MA, DeGala G, Wenger DA. The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy. Hum Genet. 1991;87:211-215.
50. Henseler M, Klein A, Reber M, Vanier MT, Landrieu P, Sandhoff K. Analysis of a splice-site mutation in the sap-precursor gene of a patient with metachromatic leukodystrophy. Am J Hum Genet. 1996;58:65-74.
51. Regis S, Filocamo M, Corsolini F, et al. An Asn→Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity. Eur J Hum Genet. 1999;7:125-130.
52. Hulkova H, Cervenkova M, Ledvinova J, et al. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation. Hum Mol Genet 2001;10:927-940.
53. Pequignot MO, Provost AC, Salle S, et al. Major role of BAX in apoptosis during retinal development and in establishment of a functional postnatal retina. Dev Dyn. 2003;228:231-238.
54. Sylvester SR, Morales C, Oko R, Griswold MD. Sulfated glycoprotein-1 (saposin precursor) in the reproductive tract of the male rat. Biol Reprod. 1989;41:941-948.
55. Bourne MC, Campbell DA, Tansley K. Hereditary degeneration of rat retina. Br J Ophthalmol. 1938;22:613-623.
56. Mullen RJ, LaVail MM. Inherited retinal dystrophy: primary defect in pigment epithelium determined with experimental rat chimeras. Science. 1976;192:799-801.
57. D'Cruz PM, Yasumura D, Weir J, et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet. 2000;9:645-651.
58. Nandrot E, Dufour EM, Provost AC, et al. Homozygous deletion in the coding sequence of the c-mer gene in RCS rats unravels general mechanisms of physiological cell adhesion and apoptosis. Neurobiol Dis. 2000;7:586-599.
59. Dowling JE, Sidman RL. Inherited retinal dystrophy in the rat. J Cell Biol. 1962;14:73-109.
60. Nguyen-Legros J, Hicks D. Renewal of photoreceptor outer segments and their phagocytosis by the retinal pigment epithelium. Int Rev Cytol. 2000;196:245-313.
61. LaVail MM. Outer segment disc shedding and phagocytosis in the outer retina. Trans Ophthalmol Soc UK. 1983;103:397-404.
62. Dufour EM, Nandrot E, Marchant D, et al. Use of microarrays and mRNA differential display methods to identify novel genes and altered signaling pathways in the RPE during the RCS rat retinal degeneration. Neurobiol. Dis. 2003;14:166-180.
63. Rakoczy PE, Mann K, Cavaney DM, Robertson T, Papadimitreou J, Constable IJ. Detection and possible functions of a cysteine protease involved in digestion of rod outer segments by retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1994;35:4100-4108.
64. Rakoczy PE, Lai CM, Baines M, Di Grandi S, Fitton JH, Constable IJ. Modulation of cathepsin D activity in retinal pigment epithelial cells. Biochem J. 1997;324:935-940.
65. Rakoczy PE, Lai M. C, Baines MG, Spilsbury K, Constable IJ. Expression of cathepsin S antisense transcripts by adenovirus in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1998;39:2095-2104.
66. WasseliusJ, Hakansson K, Johansson K, Abrahamson M, Ehinger B. Identification and localization of retinal cystatin C. Invest Ophthalmol Vis Sci. 2001;42:1901-1906.
67. Lu Q, Gore M, Zhang Q, et al. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature. 1999;398:723-728.
68. Duncan JL, LaVail MM, Yasumura D, et al. An RCS-like retinal dystrophy phenotype in mer knockout mice. Invest Ophthalmol Vis Sci 2003;44:826-838.
69. Zhang XL, Rafi MA, DeGala G, Wenger DA. Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency. Proc Natl Acad Sci USA. 1990;87:1426-1430.
70. Harzer K, Paton BC, Poulos A, et al. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur J Pediatr. 1989;149:31-39.
71. Wrobe D, Henseler M, Huettler S, Pascual Pascual SI, Chabas A, Sandhoff K. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD). J Inherit Metab Dis. 2000;23:63-76.
72. Wenger DA, DeGala G, Williams C, et al. Clinical, pathological, and biochemical studies on an infantile case of sulfatide/GM1 activator protein deficiency. Am J Med Genet 1989;33:255-265.
73. Pampols T, Pineda M, Giros ML, et al. Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant. Acta Neuropathol (Berl). 1999;97:91-97.